- Home
- AVPT vs RCKT Comparison
AVPT vs RCKT Comparison
Compare AVPT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVPT | RCKT |
|---|---|---|
| Founded | 2001 | 1999 |
| Country | United States | United States |
| Employees | 3443 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 394.2M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | AVPT | RCKT |
|---|---|---|
| Price | $14.08 | $2.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 14 |
| Target Price | ★ $16.79 | $8.85 |
| AVG Volume (30 Days) | 1.3M | ★ 1.6M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.37 |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | N/A |
| Revenue This Year | $21.74 | N/A |
| Revenue Next Year | $20.46 | $915.60 |
| P/E Ratio | $1,348.94 | ★ $3.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.84 | $2.51 |
| 52 Week High | $15.58 | $5.45 |
Technical Indicators
Market Signals| Indicator | AVPT | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 62.57 | 28.87 |
| Support Level | $12.21 | N/A |
| Resistance Level | $14.39 | $3.67 |
| Average True Range (ATR) | 0.50 | 0.21 |
| MACD | 0.08 | -0.09 |
| Stochastic Oscillator | 89.77 | 7.23 |
Price Performance
Historical ComparisonAbout AVPT AvePoint Inc.
AvePoint Inc is a provider of modern data protection, enabling organizations to secure, govern, and operationalize data at scale across cloud ecosystems. Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as it adopt cloud collaboration and artificial intelligence (AI)-driven developed tools and workflows. Its products and services are sold throughout the world, through direct and indirect sales channels.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.